$100,000 H-1B visa is a gamble that could protect US jobs
Werte in diesem Artikel
President Donald Trump is taking yet another gamble on immigration, betting that he can force companies to compete for skilled American engineers and tech workers rather than hire foreign workers through the popular H-1B visa program. Employers won’t like it — but reform of the program is long overdue. The overhaul, signed by the president Friday night, escalates the price of entry to $100,000 per worker, to be paid by the company. And the costs don’t stop there. Trump also wants a revision of prevailing wage rules to ensure that visa-holders get paid the same as Americans — a change that should further discourage companies from importing foreign labor. The plan — which may face legal challenges — preserves H-1B visas as a last resort in fields where talent is scarce, but tilts the playing field toward American workers, answering critics in and out of MAGA who complain that companies are addicted to hiring cheaper foreign workers. Tech companies, which have relied on H-1Bs for years, could be the biggest losers under the new rules. Some tech titans are already complaining thWeiter zum vollständigen Artikel bei Korea Times
Übrigens: Visa und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Protect Pharmaceutical
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Protect Pharmaceutical
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Korea Times
Nachrichten zu Visa Inc.
Analysen zu Visa Inc.
Datum | Rating | Analyst | |
---|---|---|---|
17.07.2025 | Visa Outperform | RBC Capital Markets | |
17.07.2025 | Visa Outperform | Bernstein Research | |
30.04.2025 | Visa Buy | UBS AG | |
30.04.2025 | Visa Overweight | JP Morgan Chase & Co. | |
30.04.2025 | Visa Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
17.07.2025 | Visa Outperform | RBC Capital Markets | |
17.07.2025 | Visa Outperform | Bernstein Research | |
30.04.2025 | Visa Buy | UBS AG | |
30.04.2025 | Visa Overweight | JP Morgan Chase & Co. | |
30.04.2025 | Visa Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
18.05.2018 | Visa Neutral | UBS AG | |
15.04.2016 | Visa Neutral | Compass Point | |
24.07.2015 | Visa Hold | Topeka Capital Markets | |
24.07.2015 | Visa Mkt Perform | FBR Capital | |
30.01.2015 | Visa Mkt Perform | FBR Capital |
Datum | Rating | Analyst | |
---|---|---|---|
01.11.2012 | Visa sell | UBS AG | |
12.09.2012 | Visa sell | UBS AG | |
26.07.2012 | Visa sell | UBS AG | |
09.07.2012 | Visa sell | UBS AG | |
11.12.2008 | Visa underperform | Cowen and Company, LLC |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Visa Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen